Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > SPCEO1 & WINO
View:
Post by PWIB123 on Mar 12, 2023 11:05pm

SPCEO1 & WINO

Gentlemen, you've been mostly silent here lately, and I don't blame you.  I'm not sure there's much to add until we see how things play out.  I feel trapped and would love to hear your thoughts if you have any on the current state of affairs.
Comment by SPCEO1 on Mar 13, 2023 12:02am
You are right, there is not much else to say at this point. THTX has to deliver on sales and cost cutting and all will be kinda, sorta alright if they do. I personally consider NASH to be a non-starter but might be surprised on that front. As I have said, I will believe it when I see it. If TH-1902 gets past the scientific advisory committee and the revised protocol is something the FDA approves ...more  
Comment by Wino115 on Mar 13, 2023 12:22pm
I've been pretty consistent along the lines of what SPCEO also said --they are doing what they can which is making sure sales keep growing and they are very careful on all expenses. Building the financial case was somewhat secondary when they pursued the pipeline RD assets, which is natural for a biotech. But those financials are the way to rebuild shareholder value. The pipelines reset to ...more  
Comment by SABBOBCAT on Mar 13, 2023 12:29pm
If the bleeding hinges on financials, hopefully Philippe will burn the midnight oil and try and get them out early this year. Send the positive sales signal and finally end the insanely long blackout period. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities